Corvus Pharmaceuticals, Inc. (CRVS)
20.46
+1.40
(+7.35%)
USD |
NASDAQ |
Feb 06, 16:00
20.49
+0.03
(+0.15%)
After-Hours: 20:00
Corvus Pharmaceuticals SG&A Expense (TTM) : 9.105M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Plus Therapeutics, Inc. | 11.09M |
| Geron Corp. | 160.96M |
| Jaguar Health, Inc. | 27.29M |
| Krystal Biotech, Inc. | 136.75M |